(Q37145568)

18 August 2017

1 reference

title

Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea (English)

1 reference

18 August 2017

0 references

Clostridium difficile

0 references

0 references

5

Herbert L DuPont

1 reference

18 August 2017

Kevin W Garey

1

1 reference

18 August 2017

Miguel Salazar

series ordinal

2

1 reference

18 August 2017

Dhara Shah

series ordinal

3

1 reference

18 August 2017

Richard Rodrigue

series ordinal

4

1 reference

18 August 2017

language of work or name

English

0 references

publication date

22 April 2008

1 reference

Annals of Pharmacotherapy

18 August 2017

published in

1 reference

18 August 2017

volume

42

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

827-835

1 reference

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

18 August 2017

cites work

1 reference

Past, present, and future therapies for Clostridium difficile-associated disease

21 January 2018

1 reference

Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters

21 January 2018

1 reference

In vitro synergy studies with Clostridium difficile

21 January 2018

1 reference

Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel

21 January 2018

1 reference

In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada

21 January 2018

1 reference

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

21 January 2018

1 reference

In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species

21 January 2018

1 reference

In vitro activity and fecal concentration of rifaximin after oral administration

21 January 2018

1 reference

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

21 January 2018

1 reference

Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections

21 January 2018

1 reference

Development potential of rifalazil and other benzoxazinorifamycins

21 January 2018

1 reference

Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

Oral vancomycin for antibiotic-associated pseudomembranous colitis

21 January 2018

1 reference

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile

21 January 2018

1 reference

The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers

21 January 2018

1 reference

Successful treatment with rifampin for fulminant antibiotics-associated colitis in a patient with non-Hodgkin's lymphoma

21 January 2018

1 reference

Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1K675

1 reference

18 August 2017

1 reference